CanSino Biologics Inc
688185
Company Profile
Business description
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing, and commercialization of vaccine products for human use. Its products are Menhycia and Menphecia; Convidecia, Convidecia Air, and XBB.1.5 Variant; Ad5-EBOV; PCV13i; PBPV; and DTcP Infant. Its geographic areas are PRC and Overseas. It generates the majority of its revenue from the PRC.
Contact
185 South Avenue
401-420, 4th Floor, Biomedical Park
TEDA West District
Tianjin
CHNT: +86 4009222099
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,105
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,510.70 | 43.70 | 0.52% |
CAC 40 | 7,873.83 | 23.73 | 0.30% |
DAX 40 | 23,638.56 | 72.02 | 0.31% |
Dow JONES (US) | 42,140.43 | 269.67 | -0.64% |
FTSE 100 | 8,602.92 | 2.06 | -0.02% |
HKSE | 23,108.27 | 441.19 | -1.87% |
NASDAQ | 19,010.09 | 301.74 | 1.61% |
Nikkei 225 | 38,183.26 | 539.00 | 1.43% |
NZX 50 Index | 12,786.74 | 109.99 | 0.87% |
S&P 500 | 5,886.55 | 42.36 | 0.72% |
S&P/ASX 200 | 8,269.00 | 35.50 | 0.43% |
SSE Composite Index | 3,374.87 | 5.63 | 0.17% |